The National Oncology Network in Poland faces criticism for failing to ensure equal access to cancer treatment for patients due to incomplete implementation and operational disparities between hospitals.
The National Oncology Network (KSO) in Poland aims to provide equal access and high-quality cancer treatment. However, experts noted during a recent debate that the system has not been fully implemented and there are significant disparities among hospitals, leading to unequal access for patients. Key issues highlighted include the absence of the electronic DiLO card and a lack of standardization in the treatment process, which undermine the intended goals of the network.
Professor Piotr Rutkowski, the chairman of the Polish Oncology Society, emphasized that one of the critical missing components is the electronic DiLO card, which is essential for tracking cancer care processes. Furthermore, he noted the need for quality indicators to ensure that the system functions correctly, as current data suggest operational inefficiencies. Meanwhile, Michał Dzięgielewski, the representative of the National Health Fund (NFZ), underlined the central role of coordinators and consortia in the oncology care system and pointed out the pressing challenges in implementing these necessary tools.
The disparities in treatment access raise significant concerns about the effectiveness of the KSO and its potential impact on patient outcomes. As the network continues to develop, addressing these foundational issues will be crucial for ensuring that all cancer patients in Poland receive the equitable care they deserve, regardless of their location or the specific hospital they attend.
